Purpose We determined the reasons for radioiodine thyroid remnant ablation, and the
procedure's necessity based on postsurgical remnant size, in patients with putatively “low …

Background: International best-practice guidelines recommend completion thyroidectomy
and radioiodine remnant ablation (RRA) for patients with differentiated thyroid cancer …

Objective The mute question is whether patients with DTC of intermediate risk of recurrence,
second most common presentation, who were surgically ablated in the first place, ever …

Purpose Typically formulated by investigators from “world centres of excellence,”
differentiated thyroid carcinoma (DTC) management guidelines may have more limited …

Objective: To assess the e ectiveness of radioactive iodine (RAI) ablation among patients
with intermediate-risk di erentiated thyroid cancer (DTC) following surgery. Subjects and …

Purpose We performed a systematic review and a meta-analysis to investigate the
successful ablation rate after radioiodine (RAI) administration in patients with differentiated …

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy
in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate …

Purpose To compare disease-specific survival and recurrence-free survival (RFS) after
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …

Low‐risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Background In differentiated thyroid cancer (DTC) patients at intermediate risk of
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …